1 April 2023 false Taxfiler 2024.6 08323223business:PrivateLimitedCompanyLtd2023-04-012024-03-31 083232232023-03-31 083232232023-04-012024-03-31 08323223business:AuditExemptWithAccountantsReport2023-04-012024-03-31 08323223business:FilletedAccounts2023-04-012024-03-31 083232232024-03-31 08323223business:Director12023-04-012024-03-31 08323223business:Director22023-04-012024-03-31 08323223business:RegisteredOffice2023-04-012024-03-31 083232232023-03-31 08323223core:WithinOneYear2024-03-31 08323223core:WithinOneYear2023-03-31 08323223core:AfterOneYear2024-03-31 08323223core:AfterOneYear2023-03-31 08323223core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 08323223core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 08323223core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 08323223core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 08323223core:PreviouslyStatedAmount2024-03-31 08323223core:PreviouslyStatedAmount2023-03-31 08323223business:SmallEntities2023-04-012024-03-31 08323223countries:EnglandWales2023-04-012024-03-31 08323223core:PlantMachinery2023-04-012024-03-31 08323223core:FurnitureFittings2023-04-012024-03-31 08323223core:Goodwill2023-03-31 08323223core:Goodwill2024-03-31 08323223core:Goodwill2023-04-012024-03-31 08323223core:LandBuildings2023-03-31 08323223core:PlantMachinery2023-03-31 08323223core:FurnitureFittings2023-03-31 08323223core:LandBuildings2023-04-012024-03-31 08323223core:LandBuildings2024-03-31 08323223core:PlantMachinery2024-03-31 08323223core:FurnitureFittings2024-03-31 08323223business:OrdinaryShareClass12023-04-012024-03-31 08323223business:OrdinaryShareClass12022-04-012023-03-31 08323223business:OrdinaryShareClass22023-04-012024-03-31 08323223business:OrdinaryShareClass22022-04-012023-03-31 08323223business:AllOrdinaryShares2023-04-012024-03-31 08323223business:AllOrdinaryShares2022-04-012023-03-31 083232232022-04-012023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 08323223 (England and Wales)
HALLS PHARMACY ( NORTH EAST ) LIMITED Unaudited accounts for the year ended 31 March 2024
HALLS PHARMACY ( NORTH EAST ) LIMITED Unaudited accounts Contents
Page
- 2 -
HALLS PHARMACY ( NORTH EAST ) LIMITED Company Information for the year ended 31 March 2024
Directors
Ayaz Akram Abdur Razzak
Company Number
08323223 (England and Wales)
Registered Office
6 KENSINGTON AVENUE GOSFORTH NEWCASTLE UPON TYNE NE3 2HP
Accountants
Caldwell House Consulting 44 Caldwell Road Birmingham West Midlands B9 5TQ
- 3 -
HALLS PHARMACY ( NORTH EAST ) LIMITED Statement of financial position as at 31 March 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
337,048 
374,498 
Tangible assets
260,279 
17,326 
Investments
1,149,092 
1,149,092 
1,746,419 
1,540,916 
Current assets
Inventories
64,376 
45,962 
Debtors
236,271 
37,604 
Cash at bank and in hand
66,473 
48,596 
367,120 
132,162 
Creditors: amounts falling due within one year
(112,758)
(133,459)
Net current assets/(liabilities)
254,362 
(1,297)
Total assets less current liabilities
2,000,781 
1,539,619 
Creditors: amounts falling due after more than one year
(1,658,884)
(1,088,542)
Provisions for liabilities
Deferred tax
(990)
(1,208)
Net assets
340,907 
449,869 
Capital and reserves
Called up share capital
200 
200 
Profit and loss account
340,707 
449,669 
Shareholders' funds
340,907 
449,869 
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 18 October 2024 and were signed on its behalf by
Ayaz Akram Director Company Registration No. 08323223
- 4 -
HALLS PHARMACY ( NORTH EAST ) LIMITED Notes to the Accounts for the year ended 31 March 2024
1
Statutory information
HALLS PHARMACY ( NORTH EAST ) LIMITED is a private company, limited by shares, registered in England and Wales, registration number 08323223. The registered office is 6 KENSINGTON AVENUE, GOSFORTH, NEWCASTLE UPON TYNE, NE3 2HP.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover comprises the invoiced value of goods and pharmacy services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
18% reducing balance basis
Fixtures & fittings
18% reducing balance basis
Intangible fixed assets
Intangible fixed assets (including purchased goodwill) is amortised at rates calculated to write off the assets on a straight basis over their estimated useful economic lives. Impairment of intangible fixed assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 April 2023
748,998 
At 31 March 2024
748,998 
Amortisation
At 1 April 2023
374,500 
Charge for the year
37,450 
At 31 March 2024
411,950 
Net book value
At 31 March 2024
337,048 
At 31 March 2023
374,498 
- 5 -
HALLS PHARMACY ( NORTH EAST ) LIMITED Notes to the Accounts for the year ended 31 March 2024
5
Tangible fixed assets
Land & buildings 
Plant & machinery 
Fixtures & fittings 
Total 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At 1 April 2023
- 
13,028 
75,831 
88,859 
Additions
246,072 
- 
- 
246,072 
At 31 March 2024
246,072 
13,028 
75,831 
334,931 
Depreciation
At 1 April 2023
- 
6,540 
64,993 
71,533 
Charge for the year
- 
1,168 
1,951 
3,119 
At 31 March 2024
- 
7,708 
66,944 
74,652 
Net book value
At 31 March 2024
246,072 
5,320 
8,887 
260,279 
At 31 March 2023
- 
6,488 
10,838 
17,326 
6
Investments
Subsidiary undertakings 
£ 
Valuation at 1 April 2023
1,149,092 
Valuation at 31 March 2024
1,149,092 
7
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
10,106 
37,604 
Other debtors
226,165 
- 
236,271 
37,604 
8
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Trade creditors
100,231 
115,153 
Taxes and social security
11,285 
16,148 
Loans from directors
1,242 
2,158 
112,758 
133,459 
9
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Bank loans
1,376,438 
811,596 
Amounts owed to group undertakings and other participating interests
262,446 
276,946 
Other creditors
20,000 
- 
1,658,884 
1,088,542 
- 6 -
HALLS PHARMACY ( NORTH EAST ) LIMITED Notes to the Accounts for the year ended 31 March 2024
10
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
100 Ordinary shares - Class B of £1 each
100 
100 
200 
200 
11
Average number of employees
During the year the average number of employees was 12 (2023: 11).
- 7 -